We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+8.91%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$1.77B
AUM Growth
+$297M
Cap. Flow
+$195M
Cap. Flow %
11%
Top 10 Hldgs %
25.89%
Holding
186
New
46
Increased
63
Reduced
28
Closed
46

Top Buys

Rank Stock Value
1
CPAY icon
Corpay
CPAY
+$50.4M
2
BMY icon
Bristol-Myers Squibb
BMY
+$40.6M
3
CNC icon
Centene
CNC
+$33.7M
4
CLVT icon
Clarivate
CLVT
+$27.5M
5
BAX icon
Baxter International
BAX
+$23.8M

Top Sells

Rank Stock Value
1
APP icon
Applovin
APP
+$35.3M
2
CRM icon
Salesforce
CRM
+$28.3M
3
FLEX icon
Flex
FLEX
+$21.2M
4
IPGP icon
IPG Photonics
IPGP
+$18.1M
5
LYFT icon
Lyft
LYFT
+$17.6M

Sector Composition

Rank Sector Weight
1 Technology 30.43%
2 Healthcare 14.56%
3 Communication Services 14.3%
4 Consumer Discretionary 11.94%
5 Industrials 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TZOO icon
126
Travelzoo
TZOO
$73.9M
$1.84M 0.1%
305,101
-177,596
-37% -$907K
SA
127
Seabridge Gold
SA
$3.36B
$1.69M 0.1%
+130,768
New +$1.62M
FARO
128
DELISTED
Faro Technologies
FARO
$1.67M 0.09%
+67,720
New +$1.88M
ATVI
129
DELISTED
Activision Blizzard
ATVI
$1.61M 0.09%
+18,847
New +$1.46M
ASTL icon
130
Algoma Steel
ASTL
$468M
$1.47M 0.08%
182,358
+4,110
+2% +$31.4K
ZD icon
131
Ziff Davis
ZD
$2B
$1.43M 0.08%
+18,361
New +$1.5M
WHR icon
132
Whirlpool
WHR
$2.75B
$1.38M 0.08%
+10,463
New +$1.49M
WRK
133
DELISTED
WestRock Company
WRK
$1.36M 0.08%
+44,476
New +$1.47M
LEXX icon
134
Lexaria Bioscience
LEXX
$9.07M
$1.29M 0.07%
31,540
STRT icon
135
STRATTEC Security
STRT
$349M
$984K 0.06%
43,250
+1,127
+3% +$24.6K
DOMO icon
136
Domo
DOMO
$189M
$946K 0.05%
+66,679
New +$939K
MAGN
137
Magnera Corp
MAGN
$466M
$945K 0.05%
22,784
+563
+3% +$26K
PHX
138
DELISTED
PHX Minerals
PHX
$902K 0.05%
344,269
+8,151
+2% +$25.9K
LUXE
139
LuxExperience B.V.
LUXE
$1.11B
$576K 0.03%
81,985
-91,040
-53% -$827K
ILLM
140
DELISTED
illumin Holdings Inc. Common Shares
ILLM
$155K 0.01%
97,700
-89,936
-48% -$150K
AA icon
141
Alcoa
AA
$13.6B
-49,739
Closed -$2.26M
ABM icon
142
ABM Industries
ABM
$2.81B
-109,468
Closed -$4.86M
ARLO icon
143
Arlo Technologies
ARLO
$1.59B
-213,637
Closed -$750K
BKNG icon
144
Booking.com
BKNG
$160B
-196,600
Closed -$15.8M
BWA icon
145
BorgWarner
BWA
$14.1B
-118,459
Closed -$4.2M
CBT icon
146
Cabot Corp
CBT
$4.46B
-21,168
Closed -$1.41M
CCS icon
147
Century Communities
CCS
$1.96B
-48,090
Closed -$2.4M
CIVI
148
DELISTED
Civitas Resources
CIVI
-127,363
Closed -$7.38M
CLBT icon
149
Cellebrite
CLBT
$3.97B
-150,308
Closed -$655K
CPRI icon
150
Capri Holdings
CPRI
$1.75B
-144,891
Closed -$8.31M

Similar funds

Invenomic Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Invenomic Capital Management held 186 positions worth $1.77B, up 20% from $1.47B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Invenomic Capital Management deployed $195M of net new capital in Q1 2023, opening 46 new positions and adding to 63 existing holdings. Its largest new stake was Corpay: 248,424 shares worth $52.4M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Applovin, an estimated $35.3M trimmed.

  • Invenomic Capital Management's largest Q1 2023 buy was Corpay: 248,424 shares worth $52.4M.
  • Invenomic Capital Management added most to Centene in Q1 2023, an estimated $33.7M increase.
  • Invenomic Capital Management's biggest Q1 2023 reduction was Applovin, cutting an estimated $35.3M.
  • Invenomic Capital Management fully exited Salesforce in Q1 2023, selling an estimated $28.3M.
  • Invenomic Capital Management's ten largest holdings make up 26% of its $1.77B portfolio in Q1 2023.
  • Invenomic Capital Management opened 46 new positions and closed 46 in Q1 2023.
  • Invenomic Capital Management's portfolio value rose 20% quarter-over-quarter to $1.77B.

Based on Invenomic Capital Management's 13F filing for Q1 2023, filed 15 May 2023.